Skip to content
★ Sign in to follow
TG

Talkmed Group Limited Stock: price and insider trades · Singapore

ISIN SG2G61000003SG·

No insider purchase over the last 90 days. The latest, by Chandra Das S/O Rajagopal Sitaram, was filed 30 Mar 2022.

Talkmed Group Limited: what insiders have been doing

Talkmed Group Limited is a listed company. Its insiders report their share dealings to SGX. Talkmed Group Limited has had no insider filing for more than a year; the last one goes back to 1 January 2024.

Looking back to 2018, when coverage begins, insiders filed 10 purchases and no sales.

These figures are compiled from regulatory filings published by SGX. They describe what insiders did and are not a recommendation.

Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
10 ops. · all time
Sell Volume
n/a
n/a

Financial data

· cache

Last declaration on 1 January 2024
Declarations12 total
  • ●
    Director/CEOExecutives(filed)
    0SGX
    ShareSGX-STISIN SG2G61000003SGX:SFXR0G6ASZD59AOZ
  • ▲
    Director/CEOExecutives
    0SGX
    101,300 sharesShareSGX-STISIN SG2G61000003SGX:D2NC2XFQ4G1Q1SVN
    Canonical exit: 26 Jun 2022 (T+90)
  • ●
    Director/CEOExecutives(filed)
    0SGX
    ShareSGX-STISIN SG2G61000003SGX:NX6IXSW31974G8DW
  • ▲
    Director/CEOExecutives
    0SGX
    10,000 sharesShareSGX-STISIN SG2G61000003SGX:WI3H0GL05CM7XISW
    Canonical exit: 16 Mar 2020 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    37,000 sharesShareSGX-STISIN SG2G61000003SGX:UITZEIP96PZTSSDH
    Canonical exit: 13 Feb 2020 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    327,000 sharesShareSGX-STISIN SG2G61000003SGX:28SSG2HXRPGRNA03
    Canonical exit: 31 Dec 2019 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    300,000 sharesShareSGX-STISIN SG2G61000003SGX:XGUADC5A5SWSLDH7
    Canonical exit: 12 Sept 2019 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    50,000 sharesShareSGX-STISIN SG2G61000003SGX:H90BZCX055ZZ7EOM
    Canonical exit: 8 Aug 2019 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    27,100 sharesShareSGX-STISIN SG2G61000003SGX:ONFET2DRN91BJNAX
    Canonical exit: 6 Aug 2019 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    40,000 sharesShareSGX-STISIN SG2G61000003SGX:XHX44Y0VYJR9TYF1
    Canonical exit: 11 Nov 2018 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    73,900 sharesShareSGX-STISIN SG2G61000003SGX:OENWW1XAVTI59462
    Canonical exit: 30 Sept 2018 (T+90)
  • ▲
    Director/CEOExecutives
    0SGX
    26,100 sharesShareSGX-STISIN SG2G61000003SGX:NHXA7O8FUPGILDBD
    Canonical exit: 20 Sept 2018 (T+90)

12 of 12 declarations

About Talkmed Group Limited

Talkmed Group Limited is a company listed on the XSES market, specializing in healthcare services. It focuses on improving access to medical care and health technology.